Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples